NH DRUG PRICE RELIEF
NH needs to PASS Drug Price Relief (now included in HB 1280), bipartisan legislation that address the affordability of prescription drugs. These bills are now now included in HB 1280 and represent a significant step forward to improve the health of the Granite State.
Take Action: Please Call representatives
The House will vote on HB 1280 this Tuesday, June 30th. Call your Representatives and urge them to support this comprehensive piece of legislation. Make your voice heard and let them know what drug price relief will mean to you.
No one should have to choose between their health and financial well-being, yet more and more Granite Staters are forced to do so as prescription prices increase year after year.
- Skyrocketing and unpredictable prices are forcing many to ration their medication doses or to forgo their prescriptions all together.
- In 2017, 22% of New Hampshire residents stopped taking their medications as prescribed due to cost, according to a survey by AARP. These cost-cutting measures are dangerous and put the health and well-being of my friends, neighbors and loved ones at risk.
- In the past five years prescription prices have climbed at aggressively fast rates. Since 2014, the price for all drugs, brand name and generic, increased by 32% while inflation increased only 9.69% over that same time.
- All Granite Staters are impacted, skyrocketing drug price increases are the primary driver of increasing health care premiums.
This legislation (now included in HB 1280) will help relieve all Granite Staters from overwhelming health care costs.
- Importation: This bill would allow New Hampshire to import certain high cost drugs from Canada, as such the state could provide them to residents, insurers, and MCOs at a much lower cost than they are currently paying. Canadian wholesale distributors purchase prescription drugs from US manufacturers at a lower cost than the manufactures charge US based purchasers for the same medications. Importation of drugs that would generate substantial savings will help us move toward a more open and competitive marketplace that supplies American patients with safe, effective and affordable prescription drugs.
- Transparency Board: This piece of legislation would give lawmakers and the public a look into what is going with drug prices. Gathering information on price increases may not directly force drug manufacturers to lower prescription drug prices. However, they would provide policymakers with enough data to come up with legislative remedies, and it may help nudge manufacturers to rethink unnecessary and exorbitant price increases.
- Capping co-pays for insulin: Insulin is one drug that has seen its price more than triple over the past ten years, when nothing about it has changed. Capping co-pays at $30 per prescription per month will go far in assisting the 130,000 Granite Staters who currently have diabetes.
Stories of the granite state